DARYL TIBBS: Open Payments
NPI 1265452007 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 13 payments from 8 companies in 2025. Trend: 2023 $458 · 2024 $171 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $164 |
| UCB, Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| ABBVIE INC. | 2 | $58 |
| Galderma Laboratories, L.P. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
Products named: DUPIXENT, Bimzelx, COSENTYX, SKYRIZI, LIBTAYO, Rhapsido, OTEZLA, Zoryve.
Industry payments across CA — which companies pay providers there.
